|
Volumn 353, Issue 5, 2005, Pages 525-528
|
Chlamydia pneumoniae and acute coronary syndrome [2] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
AZITHROMYCIN;
GATIFLOXACIN;
ANTIINFECTIVE AGENT;
QUINOLONE DERIVATIVE;
BACTERIAL DNA;
BACTERIUM ANTIBODY;
IMMUNOGLOBULIN G;
ACNE;
ATHEROSCLEROSIS;
BACTERIAL INFECTION;
CARDIOVASCULAR DISEASE;
CHLAMYDOPHILA PNEUMONIAE;
CLINICAL TRIAL;
COLITIS;
DIABETES MELLITUS;
DIARRHEA;
HEART MUSCLE ISCHEMIA;
HEART VENTRICLE ARRHYTHMIA;
HUMAN;
HYPERGLYCEMIA;
HYPERSENSITIVITY REACTION;
HYPOGLYCEMIA;
LETTER;
NAUSEA;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SEIZURE SUSCEPTIBILITY;
SEROLOGY;
SIDE EFFECT;
SUDDEN DEATH;
TORSADE DES POINTES;
VOMITING;
CAUSE OF DEATH;
CHEMICALLY INDUCED DISORDER;
CORONARY ARTERY DISEASE;
MORTALITY;
NOTE;
SEIZURE;
BLOOD;
GENETICS;
HEART INFARCTION;
IMMUNOLOGY;
ISOLATION AND PURIFICATION;
PROGNOSIS;
ANIMAL;
ANTIBIOTIC RESISTANCE;
ARTERIOSCLEROSIS;
DRUG COMBINATION;
DRUG EFFECT;
MICROBIOLOGY;
ANTI-BACTERIAL AGENTS;
CARDIOVASCULAR DISEASES;
CAUSE OF DEATH;
CHLAMYDOPHILA INFECTIONS;
CHLAMYDOPHILA PNEUMONIAE;
CORONARY DISEASE;
FLUOROQUINOLONES;
HUMANS;
SEIZURES;
ANTIBODIES, BACTERIAL;
DNA, BACTERIAL;
IMMUNOGLOBULIN G;
MYOCARDIAL INFARCTION;
PROGNOSIS;
ANIMALS;
ARTERIOSCLEROSIS;
AZITHROMYCIN;
DRUG RESISTANCE, BACTERIAL;
DRUG THERAPY, COMBINATION;
|
EID: 23044498657
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200508043530518 Document Type: Letter |
Times cited : (4)
|
References (0)
|